VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹584 Cr | ₹542 Cr | ₹495 Cr | ₹538 Cr | ₹494 Cr |
What is the latest Total Expenditure of VENUS REMEDIES ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹584 Cr |
| Mar2025 | ₹542 Cr |
| Mar2024 | ₹495 Cr |
| Mar2023 | ₹538 Cr |
| Mar2022 | ₹494 Cr |
How is Total Expenditure of VENUS REMEDIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹584 Cr | 7.84 | |
| Mar2025 | ₹542 Cr | 9.36 | |
| Mar2024 | ₹495 Cr | -7.91 | |
| Mar2023 | ₹538 Cr | 8.84 | |
| Mar2022 | ₹494 Cr | - | |
Compare Total Expenditure of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,948.6 Cr | 18.1% | -18.3% | 216.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 18.1% |
-18.3% |
216.3% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses